| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
94 |
| issn |
1555-1741 |
| issueIdentifier |
4 |
| pageRange |
273-94 |
| publicationName |
Core evidence |
| startingPage |
273 |
| bibliographicCitation |
Kaiser PK. Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration. Core Evid. 2008 Jul 31;2(4):273–94. PMID: 21221192; PMCID: PMC3012443. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77eabfc53015dd725ac1fb9abe1befeb |
| date |
2008-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/21221192
https://pubmed.ncbi.nlm.nih.gov/PMC3012443 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37594
https://portal.issn.org/resource/ISSN/1555-1741 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10521
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8397
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9603 |